Comparison of two oral probiotic preparations in a randomized crossover trial highlights a potentially beneficial effect of Lactobacillus paracasei NCC2461 in patients with allergic rhinitis

Clinical and Translational Allergy

Volumn 4, Issue 1, 2014, Pages

  Perrin, Yannick ^a   Nutten, Sophie ^b   Audran, Régine ^a   Berger, Bernard ^b   Bibiloni, Rodrigo ^b,c   Wassenberg, Jacqueline ^a   Barbier, Nathalie ^a   Aubert, Vincent ^a   Moulin, Julie ^b   Singh, Anurag ^b   Magliola, Corinne ^b   Mercenier, Annick ^b   Spertini, François ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b NESTLÉ RESEARCH CENTER   (Switzerland)

^c RUAKURA RESEARCH CENTRE   (New Zealand)

Author keywords

Allergic rhinitis; Clinical trial; Grass pollen; Immunomodulation; Lactobacillus paracasei; Nasal provocation test

Indexed keywords

ANTIALLERGIC AGENT; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 5; PROBIOTIC AGENT;

ADULT; ALLERGIC RHINITIS; ARTICLE; BACTERIAL STRAIN; BIFIDOBACTERIUM ANIMALIS; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; CYTOKINE PRODUCTION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GRASS POLLEN; HUMAN; IMMUNOMODULATION; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS PARACASEI; LEUKOCYTE; LIMIT OF DETECTION; MALE; NASAL PRURITUS; NOSE PROVOCATION TEST; PEAK NASAL INSPIRATORY FLOW; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN SECRETION; RANDOMIZED CONTROLLED TRIAL; VISUAL ANALOG SCALE;

EID: 84978021774     PISSN: None     EISSN: 20457022     Source Type: Journal    
DOI: 10.1186/2045-7022-4-1     Document Type: Article

References (41)

1. Kalliomaki M, Antoine JM, Herz U, Rijkers GT, Wells JM, Mercenier A: Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of allergic diseases by probiotics. J Nutr 2010, 140:713-721.
2. Laitinen K, Isolauri E: Management of food allergy: vitamins, fatty acids or probiotics? Eur J Gastroenterol Hepatol 2005, 17:1305-1311.
3. O'Flaherty JT: Lipid mediators of inflammation and allergy. Lab Invest 1982, 47:314-329.
4. Joint FAO/WHO Working Group Report on Drafting Guidelines for the Evaluation of Probiotics in Food. London, Canada; 2002.
5. Rautava S, Ruuskanen O, Ouwehand A, Salminen S, Isolauri E: The hygiene hypothesis of atopic disease-an extended version. J Pediatr Gastroenterol Nutr 2004, 38:378-388.
6. Bjorksten B, Sepp E, Julge K, Voor T, Mikelsaar M: Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 2001, 108:516-520.
7. Kalliomaki M, Kirjavainen P, Eerola E, Kero P, Salminen S, Isolauri E: Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 2001, 107:129-134.
8. Bisgaard H, Li N, Bonnelykke K, Chawes BL, Skov T, Paludan-Müller G, Stokholm J, Smith B, Krogfelt KA: Reduced diversity of the intestinal microbiota during infancy is associated with increased risk of allergic disease at school age. J Allergy Clin Immunol 2011, 128:646-652.
9. Abrahamsson TR, Jakobsson HE, Andersson AF, Björkstén B, Engstrand L, Jenmalm MC: Low diversity of the gut microbiota in infants with atopic eczema. J Allergy Clin Immunol 2012, 129:434-440.
10. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E: Probiotics in primary prevention of atopic disease: A randomised placebo-controlled trial. Lancet 2001, 357:1076-1079.
11. Viljanen M, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, Tuure T, Kuitunen M: Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: A double-blind placebo-controlled trial. Allergy 2005, 60:494-500.
12. Weston S, Halbert A, Richmond P, Prescott SL: Effects of probiotics on atopic dermatitis: A randomised controlled trial. Arch Dis Child 2005, 90:892-897.
13. Taylor AL, Dunstan JA, Prescott SL: Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: A randomized controlled trial. J Allergy Clin Immunol 2007, 119:184-191.
14. Michail SK, Stolfi A, Johnson T, Onady GM: Efficacy of probiotics in the treatment of pediatric atopic dermatitis: A meta-analysis of randomized controlled trials. Ann Allergy Asthma Immunol 2008, 101:508-516.
15. Ismail IH, Licciardi PV, Tang ML: Probiotic effects in allergic disease. J Paediatr Child Health 2013, 49:709-715.
16. Helin T, Haahtela S, Haahtela T: No effect of oral treatment with an intestinal bacterial strain, Lactobacillus rhamnosus (ATCC 53103), on birch-pollen allergy: A placebo-controlled double-blind study. Allergy 2002, 57:243-246.
17. Tamura M, Shikina T, Morihana T, Hayama M, Kajimoto O, Sakamoto A, Kajimoto Y, Watanabe O, Nonaka C, Shida K, Nanno M: Effects of probiotics on allergic rhinitis induced by Japanese cedar pollen: randomized double-blind, placebo-controlled clinical trial. Int Arch Allergy Immunol 2007, 143:75-82.
18. Wang MF, Lin HC, Wang YY, Hsu CH: Treatment of perennial allergic rhinitis with lactic acid bacteria. Pediatr Allergy Immunol 2004, 15:152-158.
19. Peng GC, Hsu CH: The efficacy and safety of heat-killed Lactobacillus paracasei for treatment of perennial allergic rhinitis induced by housedust mite. Pediatr Allergy Immunol 2005, 16:433-438.
20. Xiao JZ, Kondo S, Yanagisawa N, Takahashi N, Odamaki T, Iwabuchi N, Miyaji K, Iwatsuki K, Togashi H, Enomoto K, Enomoto T: Probiotics in the treatment of Japanese cedar pollinosis: A double-blind placebo-controlled trial. Clin Exp Allergy 2006, 36:1425-1435.
21. Ivory K, Chambers SJ, Pin C, Prieto E, Arques JL, Nicoletti C: Oral delivery of Lactobacillus casei Shirota modifies allergen-induced immune responses in allergic rhinitis. Clin Exp Allergy 2008, 38:1282-1289.
22. Singh A, Hacini-Rachinel F, Gosoniu ML, Bourdeau T, Holvoet S, Doucet-Ladeveze R, Beaumont M, Mercenier A, Nutten S: Immune-modulatory effect of probiotic Bifidobacterium lactis NCC2818 in individuals suffering from seasonal allergic rhinitis to grass pollen: An exploratory, randomized, placebo-controlled clinical trial. Eur J Clin Nutr 2013, 67:161-167.
23. Wassenberg J, Nutten S, Audran R, Barbier N, Aubert V, Moulin J, Mercenier A, Spertini F: Effect of Lactobacillus paracasei ST11 on a nasal provocation test with grass pollen in allergic rhinitis. Clin Exp Allergy 2011, 41:565-573.
24. Ouwehand AC, Nermes M, Collado MC, Rautonen N, Salminen S, Isolauri E: Specific probiotics alleviate allergic rhinitis during the birch pollen season. World J Gastroenterol 2009, 15:3261-3268.
25. Deruaz C, Leimgruber A, Berney M, Pradervand E, Spertini F: Levocetirizine better protects than desloratadine in a nasal provocation with allergen. J Allergy Clin Immunol 2004, 113:669-676.
26. Zweiman B, Getsy J, Kalenian M, Lane A, Schwartz LB, Doty R, Lanza D: Nasal airway changes assessed by acoustic rhinometry and mediator release during immediate and late reactions to allergen challenge. J Allergy Clin Immunol 1997, 100:624-631.
27. Ganslmayer M, Spertini F, Rahm F, Terrien MH, Mosimann B, Leimgruber A: Evaluation of acoustic rhinometry in a nasal provocation test with allergen. Allergy 1999, 54:974-979.
28. Terrien MH, Rahm F, Fellrath JM, Spertini F: Comparison of the effects of terfenadine with fexofenadine on nasal provocation tests with allergen. J Allergy Clin Immunol 1999, 103:1025-1030.
29. Erin EM, Zacharasiewicz AS, Nicholson GC, Tan AJ, Higgins LA, Williams TJ, Murdoch RD, Durham SR, Barnes PJ, Hansel TT: Topical corticosteroid inhibits interleukin-4, -5 and -13 in nasal secretions following allergen challenge. Clin Exp Allergy 2005, 35:1608-1614.
30. Bensch GW, Nelson HS, Borish LC: Evaluation of cytokines in nasal secretions after nasal antigen challenge: lack of influence of antihistamines. Ann Allergy Asthma Immunol 2002, 88:457-462.
31. Simpson PJ, Fitzgerald GF, Stanton C, Ross RP: The evaluation of a mupirocin-based selective medium for the enumeration of bifidobacteria from probiotic animal feed. J Microbiol Methods 2004, 57:9-16.
32. Ibnou-Zekri N, Schiffrin EJ, Von der Weid T: Divergent patterns of colonization and immune response elicited from two intestinal Lactobacillus strains that display similar properties in vitro. Infect Immun 2003, 71:428-436.
33. Pellaton C, Nutten S, Thierry AC, Boudousquié C, Barbier N, Blanchard C, Corthésy B, Mercenier A, Spertini F: Intragastric and intranasal administration of lactobacillus paracasei NCC2461 modulates allergic airway inflammation in mice. Int J Inflam 2012, 2012:686739.
34. Aalberse RC, Stapel SO, Schuurman J, Rispens T: Immunoglobulin G4: An odd antibody. Clin Exp Allergy 2009, 39:469-477.
35. Marschan E, Kuitunen M, Kukkonen K, Poussa T, Sarnesto A, Haahtela T, Korpela R, Savilahti E, Vaarala O: Probiotics in infancy induce protective immune profiles that are characteristic for chronic low-grade inflammation. Clin Exp Allergy 2008, 38:611-618.
36. Vliagoftis H, Kouranos VD, Betsi GI, Falagas ME: Probiotics for the treatment of allergic rhinitis and asthma: systematic review of randomized controlled trials. Ann Allergy Asthma Immunol 2008, 101:570-579.
37. Miettinen M, Veckman V, Latvala S, Sareneva T, Matikainen S, Julkunen I: Live Lactobacillus rhamnosus and Streptococcus pyogenes differentially regulate Toll-like receptor (TLR) gene expression in human primary macrophages. J Leukoc Biol 2008, 84:1092-1100.
38. Miettinen M, Matikainen S, Vuopio-Varkila J, Pirhonen J, Varkila K, Kurimoto M, Julkunen I: Lactobacilli and streptococci induce interleukin-12 (IL-12), IL-18, and gamma interferon production in human peripheral blood mononuclear cells. Infect Immun 1998, 66:6058-6062.
39. Amati L, Pepe M, Passeri ME, Mastronardi ML, Jirillo E, Covelli V: Toll-like receptor signaling mechanisms involved in dendritic cell activation: potential therapeutic control of T cell polarization. Curr Pharm Des 2006, 12:4247-4254.
40. Ozdemir C, Akdis M, Akdis CA: T-cell response to allergens. Chem Immunol Allergy 2010, 95:22-44.
41. Schmidt-Weber CB, Akdis M, Akdis CA: TH17 cells in the big picture of immunology. J Allergy Clin Immunol 2007, 120:247-254.